Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Polycystic Ovary Syndrome 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Pancreatic Neoplasms 1Paclitaxel-induced Neuropathy 1Obesity 1Neoplasms 1Insulin Resistance 1Hyperandrogenism 1Hirsutism 1Dyslipidemias 1Agnosia 1AML 1

Interventions

Fluorouracil 498Bevacizumab 476Oxaliplatin 450Leucovorin 442Irinotecan 408Cetuximab 318Capecitabine 317pembrolizumab 142Folfox protocol 128Panitumumab 117regorafenib 105Colonoscopy 88Nivolumab 82IFL protocol 81Drug Therapy 77trifluridine tipiracil drug combination 73Radiotherapy 66HMPL-013 65Blood Specimen Collection 52Gemcitabine 49Specimen Handling 47Standard of Care 45Neoadjuvant Therapy 45Magnetic Resonance Spectroscopy 44Biopsy 44Chemotherapy, Adjuvant 41Trifluridine 40atezolizumab 39Cyclophosphamide 39Surveys and Questionnaires 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Magnesium × Clear all
NCT01157052 2014-10-01

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

AHS Cancer Control Alberta

Phase 1 Unknown
15 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01087658 2013-06-21

GLUTOX

Sanofi

Phase 3 Completed
200 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡